Why did BIIB.SW stock fall sharply intraday on 09 Mar 2026?

BIIB.SW stock fell **-36.44%** intraday on 09 Mar 2026. The drop outpaced the Healthcare sector, and the reported volume (**1.00**) suggests a possible data anomaly or single large trade. Confirm SIX trade reports and company releases for the cause.

What is Meyka AI's outlook for BIIB.SW stock?

Meyka AI's forecast model projects **CHF189.88** in one year for BIIB.SW stock, implying **28.77%** upside from **CHF147.46**. This is a model projection and not a guarantee; view it alongside fundamentals and regulatory news.

Which levels should traders watch for BIIB.SW stock after the drop?

Traders should watch support at the year low **CHF131.09**, the 50/200 moving average area at **CHF151.46**, and the prior close **CHF232.00** as resistance. Confirm levels with live SIX order books.

Does BIIB.SW stock pay a dividend and what are its key ratios?

BIIB.SW stock shows no dividend yield (dividendPerShare TTM: none). Key ratios include EPS **6.80**, reported PE **21.69**, price/book **1.20**, and cash per share **14.94**.

CH Stocks

Down 36% intraday BIIB.SW Biogen Inc. (SIX) 09 Mar 2026: catalysts to track

ByHuzaifa Zahoor March 9, 2026March 9, 2026

BIIB.SW stock plunged -36.44% intraday on 09 Mar 2026, trading at CHF147.46 on the SIX after a sharp gap from the previous close of CHF232.00. The move makes Biogen Inc. (BIIB.SW) one of today’s top losers in the Swiss session and outpaced the Healthcare sector, which fell -3.54% on the day. Traders should note the unusually low reported volume (1.00 share) and the large price swing, which suggests a market-specific event or data anomaly worth watching in real time.